Alveolar Soft Part Sarcoma Latest Advances
Find the Latest Research About Alveolar Soft Part Sarcoma
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 816 publications
Case Report: A case of early rapid recurrence of a primary intracranial alveolar soft part sarcoma with high proliferative activity and complex molecular variations.
Journal: Frontiers in oncology
Published: July 21, 2026
Alveolar soft part sarcoma in buccal mucosa of a young child.
Journal: BMJ case reports
Published: June 19, 2026
A partial response to atezolizumab in alveolar soft part sarcoma with near-complete resolution of extensive pulmonary metastases: a case report.
Journal: Frontiers in oncology
Published: May 04, 2026
Dual Inhibition of LAG-3 and PD-1 with IBI110 and Sintilimab in Advanced Alveolar Soft Part Sarcoma: A Single-Center, Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 20, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 18, 2026
Multimodality Cardiac Imaging and Multidisciplinary Collaboration in Monitoring Intracardiac Sarcoma Response to Immunotherapy.
Journal: JACC. Case reports
Published: March 25, 2026
Immunotherapy in the Treatment of Soft Tissue Sarcoma Since SARC028: An NCDB Analysis.
Journal: Journal of surgical oncology
Published: March 17, 2026
The case for tumour-agnostic reimbursement of dual immunotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 07, 2026
Sequential Checkpoint Inhibition in Pediatric Alveolar Soft Part Sarcoma: Durable Pembrolizumab Response After Atezolizumab Progression.
Journal: Pediatric blood & cancer
Published: January 07, 2026
Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series.
Journal: Therapeutics and clinical risk management
Published: December 18, 2025
Last Updated: 11/08/2026